Actis acquires US firm's drug discovery assets

Actis acquires US firm’s drug discovery assets

Mumbai-based drug discovery company Actis Biologics (ABPL) has acquired the cancer drug discovery assets of US-based CellPoint Diagnostics for an undisclosed amount.

Actis acquires US firm’s drug discovery assets

Ranbaxy to demerge drug discovery operation

Orchid enters into $100 mn licensing agreement with Merck

Actis may skip Swaraj Mazda issue

Dr Reddy`s bets big on drug discovery

JPMorgan acquires WaMu banking assets

Orchid gets USFDA nod for non-antibiotic drug

Steel deal: JSW acquires three US firms

Ranbaxy Labs, Merck tie up to develop anti-infective drugs

This entry was posted on Sunday, August 31st, 2008 at 5:08 pm and is filed under Business Standard. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Indian Stock Market

Actis acquires US firm’s drug discovery assets

Leave a Reply

Categories

Archives

Feed

Links

Subscribe by E-Mail :

Recent Posts

Recent Comments

Indian Stock Market News